CARM
Price
$0.41
Change
+$0.01 (+2.50%)
Updated
Jul 2, 02:56 PM (EDT)
Capitalization
16.3M
RDW
Price
$15.59
Change
+$0.28 (+1.83%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
2.18B
35 days until earnings call
Interact to see
Advertisement

CARM vs RDW

Header iconCARM vs RDW Comparison
Open Charts CARM vs RDWBanner chart's image
Carisma Therapeutics
Price$0.41
Change+$0.01 (+2.50%)
Volume$121
Capitalization16.3M
Redwire
Price$15.59
Change+$0.28 (+1.83%)
Volume$14.28K
Capitalization2.18B
CARM vs RDW Comparison Chart in %
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. RDW commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a Hold and RDW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (CARM: $0.40 vs. RDW: $15.31)
Brand notoriety: CARM and RDW are both not notable
CARM represents the Biotechnology, while RDW is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: CARM: 6% vs. RDW: 136%
Market capitalization -- CARM: $16.3M vs. RDW: $2.18B
CARM [@Biotechnology] is valued at $16.3M. RDW’s [@Aerospace & Defense] market capitalization is $2.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $265.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B. The average market capitalization across the [@Aerospace & Defense] industry is $20.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whileRDW’s FA Score has 0 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • RDW’s FA Score: 0 green, 5 red.
According to our system of comparison, both CARM and RDW are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 5 TA indicator(s) are bullish while RDW’s TA Score has 4 bullish TA indicator(s).

  • CARM’s TA Score: 5 bullish, 5 bearish.
  • RDW’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CARM is a better buy in the short-term than RDW.

Price Growth

CARM (@Biotechnology) experienced а -5.31% price change this week, while RDW (@Aerospace & Defense) price change was -7.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +33.17%, and the average quarterly price growth was +2.02%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +3.19%. For the same industry, the average monthly price growth was +9.77%, and the average quarterly price growth was +36.35%.

Reported Earning Dates

CARM is expected to report earnings on May 13, 2025.

RDW is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+3.19% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDW($2.18B) has a higher market cap than CARM($16.3M). CARM YTD gains are higher at: -3.319 vs. RDW (-6.987). CARM has higher annual earnings (EBITDA): -49.68M vs. RDW (-85.33M). RDW has more cash in the bank: 54.2M vs. CARM (7.74M). CARM has less debt than RDW: CARM (2.33M) vs RDW (125M). RDW has higher revenues than CARM: RDW (278M) vs CARM (20M).
CARMRDWCARM / RDW
Capitalization16.3M2.18B1%
EBITDA-49.68M-85.33M58%
Gain YTD-3.319-6.98748%
P/E RatioN/AN/A-
Revenue20M278M7%
Total Cash7.74M54.2M14%
Total Debt2.33M125M2%
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARMRDW
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 24 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AKRIX73.01N/A
N/A
Akre Focus Instl
PCLCX18.90N/A
N/A
PACE Large Co Growth Equity P
FRLAX17.30N/A
N/A
Franklin Real Estate Securities Adv
MWELX47.01N/A
N/A
MFS Global Equity R4
ADEIX17.03N/A
N/A
Ancora Dividend Value Equity I

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
+3.40%
EVGN - CARM
58%
Loosely correlated
+4.69%
INSM - CARM
39%
Loosely correlated
-3.00%
PMVP - CARM
34%
Loosely correlated
-0.94%
ABCL - CARM
32%
Poorly correlated
+1.75%
VCYT - CARM
31%
Poorly correlated
+1.07%
More

RDW and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDW has been loosely correlated with PL. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RDW jumps, then PL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDW
1D Price
Change %
RDW100%
-6.07%
PL - RDW
55%
Loosely correlated
+0.98%
ACHR - RDW
51%
Loosely correlated
-8.94%
LUNR - RDW
48%
Loosely correlated
-2.83%
EVEX - RDW
45%
Loosely correlated
-3.94%
RKLB - RDW
44%
Loosely correlated
-4.03%
More